ClinicalTrials.Veeva

Menu

Effects of Rhythmic Auditory Cueing Augments Cognitive Treadmill Walking Training in Individuals With Chronic Stroke

C

Chang Gung University

Status

Enrolling

Conditions

Stroke

Treatments

Device: Treadmill Walking Training (TW)
Device: Cognitive Treadmill Walking Training (CTW) group
Device: Cognitive Treadmill Walking Training with Rhythmic Auditory Cueing (CTW+RAC) group

Study type

Interventional

Funder types

Other
Other U.S. Federal agency

Identifiers

NCT06392945
NSTC 112-2314B-182-021

Details and patient eligibility

About

The first objective of this study is to examine the superiority of the combined rhythmic auditory cueing with cognitive treadmill training (combined group) in people with stroke as compared with the cognitive treadmill walking training (cognitive group) or treadmill walking training alone (treadmill group) (Aim 1). The study's second aim is to investigate the factors affecting the improvement in community walking capacity after interventions and to explore whether changes in community walking capacity are associated with changes in participation after interventions (Aim 2).

Full description

A single-blind, randomized controlled trial is conducted at medical centers. Ninety stroke patients will be randomized to one of the three groups. All groups will receive interventions 30 minutes per time, 3 times a week, for 4 weeks. The combined group will undertake progressive treadmill walking speed while performing a cognitive task with rhythmic auditory cueing (i.e., 110% of baseline cadence). The cognitive group will receive cognitive training while walking at a progressive speed on the treadmill. The treadmill-alone group will train only in treadmill walking with progressive speed adjusted weekly. A blinded assessor will administer three assessments. All participants will be examined for gait and cognitive performance under single-task (walking only, Stroop task only) and dual-task conditions (walking while performing the Stroop task) at baseline, post-intervention, and one-month follow-up. The primary outcome measures are gait and cognition under single- and dual-task conditions. The secondary outcome measures are the 6-minute Walk Test, Mini-BESTest, Stroke Impact Scale, and Walking Ability Questionnaire.

Enrollment

90 estimated patients

Sex

All

Ages

20 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • diagnosed with first-time stroke;
  • more than 6 months after stroke onset;
  • able to walk 10 meters;
  • no severe vision, hearing, or speech impairments;
  • understand and follow the instructions and sign the Informed Consent Form;
  • older than 20 years old.

Exclusion criteria

  • orthopedic problems affecting walking or other diseases that may interfere with study participation;
  • a score of less than 24 on the mini-mental state examination (MMSE);
  • severe balance disorder with a total score of less than 45 points Berg Balance Scale.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

90 participants in 3 patient groups

Cognitive Treadmill Walking Training with Rhythmic Auditory Cueing (CTW+RAC) group
Experimental group
Description:
The CTW+RAC group will undertake progressive treadmill walking speed while performing a cognitive task with rhythmic auditory cueing (i.e., 110% of baseline cadence).
Treatment:
Device: Cognitive Treadmill Walking Training with Rhythmic Auditory Cueing (CTW+RAC) group
Cognitive Treadmill Walking Training (CTW)
Active Comparator group
Description:
The CTW group will receive cognitive training while walking at a progressive speed on the treadmill.
Treatment:
Device: Cognitive Treadmill Walking Training (CTW) group
Treadmill Walking Training (TW)
Active Comparator group
Description:
The TW group will train only in treadmill walking with progressive speed adjusted weekly.
Treatment:
Device: Treadmill Walking Training (TW)

Trial contacts and locations

1

Loading...

Central trial contact

Li-Ling Chuang, Ph.D.; Li-Ling Chuang, Ph.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems